- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
NIH's Zerhouni: imaging is key to medicine's future
Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Dr. Elias Zerhouni, the first radiologist to serve as director of the National Institutes of Health, envisions a central role for medical imaging in 21st century medical research and practice. He predicted growth for image-guided therapies, imaging genomics, computer-based radiology applications, and molecular imaging during a lecture at the 2006 International Society for Magnetic Resonance in Medicine meeting in Seattle.
Breakthroughs that have transformed medicine rely on discoveries made at the juncture of scientific disciplines, he said. The application of computers to imaging revolutionized radiology. Real-time cine pushed cardiac imaging forward, and television adopted for x-ray technology led to interventional radiology. Imaging is no longer simply a method for creating images, but a method of extracting information for all physical scales from single molecules to the full organ.
"Today, biology is again driving new research, be it genomics or proteomics or targeted agents," Zerhouni said. "In this century, we will have to intervene before the damage is done. We need to preserve normal function, and our ability to detect patients at risk is increasing remarkably."
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
